# ğŸ“š ë§ˆìŠ¤í„° ì¸ë±ìŠ¤ (9í¸)

> ì—…ë°ì´íŠ¸: 2026-02-18 03:45

| # | P | ì œëª© | ì—°ë„ | ë°©ë²•ë¡  | ê´€ë ¨ì„± |
|---|---|------|------|--------|--------|
| 1 | ğŸ“˜ | [[02_cards_basic/Efficacy of digital cognitive behavioral therapy for moderateâ€toâ€severe symptoms|Efficacy of digital cognitive behavioral therapy for mo]] | 2020 |  | 5.9 |
| 2 | ğŸ“˜ | [[02_cards_basic/Mental health in the â€œeraâ€ of artificial intelligence technostress and the perce|Mental health in the â€œeraâ€ of artificial intelligence: ]] | 2025 |  | 5.8 |
| 3 | ğŸ“˜ | [[02_cards_basic/Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondyl|Infliximab, a TNF-alpha antagonist treatment in patient]] | 2012 |  | 5.1 |
| 4 | ğŸ“˜ | [[02_cards_basic/Psychological treatment of generalized anxiety disorder A meta-analysis|Psychological treatment of generalized anxiety disorder]] | 2014 |  | 4.6 |
| 5 | ğŸ“˜ | [[02_cards_basic/VerÃ¤nderungsmessung mit der Hospital Anxiety and Depression Scale (HADS) Ã„nderun|VerÃ¤nderungsmessung mit der Hospital Anxiety and Depres]] | 2009 |  | 3.4 |
| 6 | ğŸ“˜ | [[02_cards_basic/Ethical Decision-Making Guidelines for Mental Health Clinicians in the Artificia|Ethical Decision-Making Guidelines for Mental Health Cl]] | 2025 |  | 3.0 |
| 7 | ğŸ“˜ | [[02_cards_basic/Efficacy of treatments for anxiety disorders a meta-analysis|Efficacy of treatments for anxiety disorders: a meta-an]] | 2015 |  | 2.0 |
| 8 | ğŸ“˜ | [[02_cards_basic/Depression, illness perception and coping in rheumatoid arthritis|Depression, illness perception and coping in rheumatoid]] | 1999 |  | 1.7 |
| 9 | ğŸ“˜ | [[02_cards_basic/Self management of arthritis in primary care randomised controlled trial|Self management of arthritis in primary care: randomise]] | 2006 |  | 0.0 |